US Bancorp
KMTS

US Bancorp’s Kestra Medical Technologies KMTS Stock Holding History

US Bancorp’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$501K Buy
25,139
+25,031
+23,177% +$590K ﹤0.01% 1508
2025
Q4 		$2.86K Buy
108
+34
+46% +$876 ﹤0.01% 3684
2025
Q3 		$1.76K Buy
+74
New +$1.32K ﹤0.01% 3770

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AP
Andera Partners Paris $177M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

US Bancorp's KMTS Position: Q1 2026 in Review

US Bancorp increased its Kestra Medical Technologies (KMTS) stake by 23,177% in Q1 2026, buying an estimated $590K and bringing the position to 25,139 shares worth $501K. The position accounts for ﹤0.01% of the portfolio, ranked #1508.

US Bancorp first reported a position in KMTS in Q3 2025 and has held it in 3 quarters since. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • US Bancorp held 25,139 shares of Kestra Medical Technologies worth $501K as of Q1 2026.
  • US Bancorp bought 25,031 Kestra Medical Technologies shares in Q1 2026, an estimated $590K.
  • Kestra Medical Technologies made up ﹤0.01% of US Bancorp's portfolio in Q1 2026, its #1508 holding.
  • US Bancorp first reported a position in Kestra Medical Technologies in Q3 2025 and has held it in 3 quarters since.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.